Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
Cypress Bioscience's top competitor, I-Flow Corporation, earned an annual revenue of $1.6B.
Cypress Bioscience's smallest competitor is Citius Pharma with revenue of $90.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Citius Pharma | $65,016 | $90,000 | 9 | - |
| Empi | $52,214 | $52.0M | 500 | - |
| Accentia Biopharmaceuticals Inc | $47,628 | $4.1M | 50 | - |
| I-Flow Corporation | $69,708 | $1.6B | 1,100 | - |
| Snap Diagnostics | $49,810 | $49.0M | 125 | 17 |
| Conceptus | $67,982 | $140.7M | 125 | - |
| Fukuda Denshi USA | $50,939 | $1.8M | 25 | - |
| MegaFood | $55,538 | $17.0M | 199 | - |
| AADCO Medical | $47,331 | $13.6M | 50 | 2 |
| Hiossen | $58,666 | $25.0M | 429 | 34 |
Zippia gives an in-depth look into the details of Cypress Bioscience, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Cypress Bioscience. The employee data is based on information from people who have self-reported their past or current employments at Cypress Bioscience. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Cypress Bioscience. The data presented on this page does not represent the view of Cypress Bioscience and its employees or that of Zippia.
Cypress Bioscience may also be known as or be related to CYPRESS BIOSCIENCE INC and Cypress Bioscience.